James D. Bearden

Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers

Scott M. Lippman, Eric A. Klein, Phyllis J. Goodman et al. · JAMA · 2008 · 2.1K citations · Full text

Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Amylou C. Dueck, Tito R. Mendoza, Sandra A. Mitchell et al. · JAMA Oncology · 2015 · 979 citations · Full text

Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non–Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504

David R. Gandara, Kari Chansky, Kathy S. Albain et al. · Journal of Clinical Oncology · 2003 · 372 citations

Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma

John D. Hainsworth, Howard A. Burris, Lisa H. Morrissey et al. · Blood · 2000 · 263 citations

A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA

Debra L. Barton, Edward J. Wos, Rui Qin et al. · Supportive Care in Cancer · 2010 · 248 citations · Full text

Ncctg Trial N06ca, Health Sciences, Peripheral Nerve Injury +10